|

"Expert IVUS-Eye" vs. IVUS-guided Left Main Bifurcation PCI

RECRUITINGN/ASponsored by Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
Actively Recruiting
PhaseN/A
SponsorFederal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
Started2026-07-01
Est. completion2027-01-01
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

This is a prospective, randomized, controlled trial comparing two strategies for optimizing stent implantation during bifurcation stenting of the left main coronary artery (LM): an intravascular ultrasound (IVUS)-guided approach versus a "IVUS-trained eye" approach based on angiographic assessment and operator experience. All patients receive the same stent brand and procedure steps to minimize variability. The primary objective is to compare the planimetric stent appearance between two strategies.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* De novo lesion in an unprotected left main coronary artery, indicated for bifurcational stenting (provisional or 2-stent)
* Patient referred for elective or delayed (non-emergency) stenting
* Technical feasibility of performing IVUS
* Signed informed consent

Exclusion Criteria:

* ST-elevation myocardial infarction (STEMI) within the preceding 72 hours
* Cardiogenic shock
* Isolated (non-bifurcation) left main lesion
* Prior PCI in the target segment
* Diameter of one of the left main main branches \< 2 mm
* Occlusion in the proximal segment of one of the main left main branches without the possibility of simultaneous recanalization
* History of coronary artery bypass grafting (CABG)
* Severe comorbidity with expected life expectancy \< 1 year
* Participation in another interventional study
* Patient is a woman who is pregnant or nursing;
* Female patient of childbearing potential, i.e. who are not surgically sterile or post-menopausal (defined as no menses for 2 years without an alternative cause);
* IVUS is strictly required for pre-PCI lesion severity assessment
* Patients unable to tolerate, obtain or comply with dual antiplatelet therapy for at least 6 months in stable patients and 1 year in ACS patients;
* Known contraindication or hypersensitivity to everolimus, platinum-chromium, or to anticoagulants.

Conditions5

Chronic Coronary SyndromeCoronary Artery Disease (CAD)Coronary Bifurcation LesionHeart DiseaseLeft Main Coronary Artery Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.